Dimensional Fund Advisors LP Grows Stake in LivaNova PLC (LIVN)

Dimensional Fund Advisors LP increased its position in shares of LivaNova PLC (NASDAQ:LIVN) by 55.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 922,229 shares of the company’s stock after acquiring an additional 327,395 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.89% of LivaNova PLC worth $56,450,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in LIVN. BlackRock Inc. boosted its holdings in shares of LivaNova PLC by 16,157.4% in the 1st quarter. BlackRock Inc. now owns 2,592,889 shares of the company’s stock valued at $127,077,000 after purchasing an additional 2,576,940 shares during the last quarter. Credit Suisse AG boosted its holdings in shares of LivaNova PLC by 2,084.7% in the 1st quarter. Credit Suisse AG now owns 694,275 shares of the company’s stock valued at $34,026,000 after purchasing an additional 662,496 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of LivaNova PLC by 7.5% in the 2nd quarter. Franklin Resources Inc. now owns 5,089,070 shares of the company’s stock valued at $311,515,000 after purchasing an additional 354,956 shares during the last quarter. Point72 Asset Management L.P. raised its stake in shares of LivaNova PLC by 144.7% in the 1st quarter. Point72 Asset Management L.P. now owns 537,300 shares of the company’s stock valued at $26,333,000 after acquiring an additional 317,700 shares during the period. Finally, Investment Counselors of Maryland LLC raised its stake in shares of LivaNova PLC by 190.4% in the 2nd quarter. Investment Counselors of Maryland LLC now owns 274,365 shares of the company’s stock valued at $16,794,000 after acquiring an additional 179,886 shares during the period. Hedge funds and other institutional investors own 82.23% of the company’s stock.

In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $74.58, for a total value of $74,580.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 3,000 shares of company stock valued at $203,890 in the last three months. Insiders own 0.28% of the company’s stock.

WARNING: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2017/10/27/dimensional-fund-advisors-lp-has-56-45-million-position-in-livanova-plc-livn.html.

A number of equities analysts have recently commented on the stock. Canaccord Genuity reissued a “hold” rating and issued a $71.00 target price on shares of LivaNova PLC in a research note on Wednesday, September 20th. Jefferies Group LLC raised their target price on shares of LivaNova PLC from $76.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, September 15th. Needham & Company LLC raised shares of LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a research note on Friday, September 15th. Piper Jaffray Companies reissued an “overweight” rating and issued a $75.00 target price on shares of LivaNova PLC in a research note on Tuesday, September 12th. Finally, WBB Securities downgraded shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price target on the stock. in a research note on Tuesday, August 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $71.50.

Shares of LivaNova PLC (NASDAQ:LIVN) opened at 73.59 on Friday. The company has a market cap of $3.59 billion, a P/E ratio of 131.41 and a beta of 0.59. LivaNova PLC has a 52-week low of $40.83 and a 52-week high of $75.73. The stock has a 50 day moving average of $70.87 and a 200 day moving average of $62.14.

LivaNova PLC (NASDAQ:LIVN) last posted its earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The company had revenue of $321.40 million during the quarter, compared to the consensus estimate of $315.75 million. The business’s quarterly revenue was up .1% compared to the same quarter last year. On average, equities analysts anticipate that LivaNova PLC will post $3.25 earnings per share for the current fiscal year.

LivaNova PLC Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Institutional Ownership by Quarter for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply